Revvity Inc. $RVTY Shares Purchased by Czech National Bank

Czech National Bank increased its stake in shares of Revvity Inc. (NYSE:RVTY) by 3.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,811 shares of the company’s stock after acquiring an additional 858 shares during the period. Czech National Bank’s holdings in Revvity were worth $2,787,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC lifted its holdings in Revvity by 3.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company’s stock valued at $544,000 after purchasing an additional 187 shares in the last quarter. Ritholtz Wealth Management purchased a new position in Revvity during the first quarter valued at $210,000. Amalgamated Bank lifted its holdings in Revvity by 1.0% during the first quarter. Amalgamated Bank now owns 23,777 shares of the company’s stock valued at $2,516,000 after purchasing an additional 227 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Revvity by 11.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 13,415 shares of the company’s stock worth $1,417,000 after purchasing an additional 1,343 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its position in shares of Revvity by 21.2% during the first quarter. Farther Finance Advisors LLC now owns 796 shares of the company’s stock worth $83,000 after purchasing an additional 139 shares in the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

RVTY has been the topic of a number of recent research reports. Raymond James Financial reissued an “outperform” rating and set a $115.00 price objective (down previously from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Stifel Nicolaus lowered their price objective on Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a research note on Tuesday, July 29th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 3rd. Bank of America lowered their price objective on Revvity from $116.00 to $110.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Finally, Evercore ISI decreased their price target on Revvity from $116.00 to $115.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Ten analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $120.07.

Revvity Trading Down 1.2%

NYSE:RVTY opened at $86.68 on Friday. The stock’s 50 day moving average price is $90.03 and its 200 day moving average price is $95.31. The company has a market capitalization of $10.06 billion, a PE ratio of 36.73, a P/E/G ratio of 2.36 and a beta of 0.94. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $129.50.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. The company had revenue of $720.28 million during the quarter, compared to analysts’ expectations of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the firm earned $1.22 EPS. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, research analysts anticipate that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be issued a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.